Scholars Central

Review articlePublished 16 Jul 2016

Role of sodium status in the clinical management of diabetic nephropathy: interaction with RAAS-blockade efficacy

Authors: Martin H de Borst, Gerjan Navis

Diabetes Management

Volume 5 · Issue 3 · Pages 228–242

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Diabetic nephropathy is the leading cause of chronic kidney disease worldwide. The expanding endemic of diabetes, the high risk of premature morbidity and mortality and the incapacity of current therapies to halt progression toward renal failure urges additional treatment modalities. We will review current evidence addressing dietary sodium intake as a key determinant of renin–angiotensin–aldosterone system (RAAS)- blockade efficacy, particularly in diabetic nephropathy. High sodium intake is very common in these patients, and blunts the protective effects of RAAS-blockade on cardiovascular and renal outcomes. Moderate dietary sodium restriction restores the protective effects of RAASblockade. The data warrant monitoring of sodium intake and practical implementation of sodium restriction as a lifestyle-related intervention, mandatory as an addition to RAAS-blockade in diabetic nephropathy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Diabetes Management.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDiabetes Management
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Martin H de Borst”
  • BylineArticles whose byline prints “Gerjan Navis”